Urology
Volume 75, Issue 6 , Pages 1365-1370.e3 , June 2010

Comparison of the UCLA Integrated Staging System and the Leibovich Score in Survival Prediction for Patients With Nonmetastatic Clear Cell Renal Cell Carcinoma

  • Min-Han Tan

      Affiliations

    • Department of Medical Oncology, National Cancer Centre Singapore, Republic of Singapore
    • NCCS-VARI Laboratory of Translational Cancer Research, Singapore General Hospital, Republic of Singapore
    • Department of Epidemiology and Public Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    • Corresponding Author InformationReprint requests: Min-Han Tan, Department of Medical Oncology, National Cancer Centre, Singapore, 11 Hospital Dr, Singapore, Republic of Singapore
    • ,
  • Ravindran Kanesvaran

      Affiliations

    • Department of Medical Oncology, National Cancer Centre Singapore, Republic of Singapore
    • ,
  • Huihua Li

      Affiliations

    • Clinical Trials and Epidemiologic Sciences Division, National Cancer Centre Singapore, Republic of Singapore
    • ,
  • Hwei Ling Tan

      Affiliations

    • NCCS-VARI Laboratory of Translational Cancer Research, Singapore General Hospital, Republic of Singapore
    • ,
  • Puay Hoon Tan

      Affiliations

    • Department of Pathology, Singapore General Hospital, Republic of Singapore
    • ,
  • Chin Fong Wong

      Affiliations

    • Department of Pathology, Singapore General Hospital, Republic of Singapore
    • ,
  • Kee Seng Chia

      Affiliations

    • Department of Epidemiology and Public Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    • ,
  • Bin Tean Teh

      Affiliations

    • NCCS-VARI Laboratory of Translational Cancer Research, Singapore General Hospital, Republic of Singapore
    • Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan
    • ,
  • John Yuen

      Affiliations

    • Department of Urology, Singapore General Hospital, Republic of Singapore
    • ,
  • Tsung Wen Chong

      Affiliations

    • Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan
    • Corresponding Author InformationChong Tsung Wen, Department of Urology, Singapore General Hospital, Outram Road, Singapore 169608, Republic of Singapore

Received 8 May 2009 ,Accepted 25 July 2009.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96
  2. Hudes G, Carducci M, Tomczak P, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007;356:2271–2281
  3. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007;356:115–124
  4. Galfano A, Novara G, Iafrate M, et al. Mathematical models for prognostic prediction in patients with renal cell carcinoma. Urol Int. 2008;80:113–123
  5. Haas NB, Uzzo R. Adjuvant therapy for renal cell carcinoma. Curr Oncol Rep. 2008;10:245–252
  6. Zisman A, Pantuck AJ, Dorey F, et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol. 2001;19:1649–1657
  7. Zisman A, Pantuck AJ, Wieder J, et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol. 2002;20:4559–4566
  8. Frank I, Blute ML, Cheville JC, et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol. 2002;168:2395–2400
  9. Leibovich BC, Blute ML, Cheville JC, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003;97:1663–1671
  10. Ficarra V, Martignoni G, Lohse C, et al. External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol. 2006;175:1235–1239
  11. Han KR, Bleumer I, Pantuck AJ, et al. Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population. J Urol. 2003;170:2221–2224
  12. Patard JJ, Kim HL, Lam JS, et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol. 2004;22:3316–3322
  13. Cindolo L, Patard JJ, Chiodini P, et al. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. Cancer. 2005;104:1362–1371
  14. Fujii Y, Saito K, Iimura Y, et al. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma. J Urol. 2008;180:1290–1295discussion:1295-1296
  15. Ficarra V, Novara G, Galfano A, et al. The “Stage, Size, Grade and Necrosis” score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma. BJU Int. 2009;103:165–170
  16. Harrell FEJ, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387
  17. Harrell FE. Regression Modelling Strategies: with Applications to Linear Models, Logistic Regression and Survival Analysis. New York, NY: Springer-Verlag; 2001;
  18. Sengupta S, Lohse CM, Leibovich BC, et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer. 2005;104:511–520
  19. Chow WH, Devesa SS, Warren JL, et al. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628–1631
  20. Tan MH, Teh BT. Gene expression profiling predicts survival in clear cell renal cell carcinoma. Proc Am J Soc Clin Oncol. 2005;

 T. Min-Han and R. Kanesvaran have contributed equally to this work.

PII: S0090-4295(09)02386-3

doi: 10.1016/j.urology.2009.07.1289

Urology
Volume 75, Issue 6 , Pages 1365-1370.e3 , June 2010

Article Tools

* Image Usage & Resolution